Literature DB >> 12404223

Evolution of hepatitis C viral quasispecies after liver transplantation.

Andre C Lyra1, Xiaofeng Fan, Dorothy M Lang, Karina Yusim, Sanjay Ramrakhiani, Elizabeth M Brunt, Bette Korber, Alan S Perelson, Adrian M Di Bisceglie.   

Abstract

BACKGROUND & AIMS: To determine whether HCV quasispecies diversity correlated positively with liver disease progression after orthotopic liver transplantation (OLT).
METHODS: We studied 11 patients undergoing OLT for HCV-related cirrhosis with recurrent hepatitis C in 2 groups according to the stage of hepatic fibrosis on follow-up. The mild group had stage 1 or 2 fibrosis; the severe group, stage 3 or 4 fibrosis. HCV quasispecies diversity was assessed by cloning and sequencing in pretransplantation and posttransplantation serum samples.
RESULTS: In the mild fibrosis group, intrasample hypervariable region 1 (HVR1) genetic distance and nonsynonymous substitutions increased after OLT, whereas in the severe fibrosis group, these parameters decreased in follow-up. In contrast, intrasample diversity progressed similarly in both groups in the adjacent sequences flanking HVR1. There was an inverse correlation between the stage of hepatic fibrosis and amino acid complexity after OLT. Among all patients, the estimated rate of amino acid change was greater initially and became more constant after 36 months.
CONCLUSIONS: After OLT, a more complex HCV HVR1 quasispecies population was associated with mild disease recurrence. Among those patients with severe recurrent hepatitis C, HCV appeared to be under greater immune pressure. The greatest change in viral amino acid sequences occurred in the first 36 months after OLT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12404223     DOI: 10.1053/gast.2002.36546

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  14 in total

1.  Divergent quasispecies evolution in de novo hepatitis C virus infection associated with bone marrow transplantation.

Authors:  Weihua Wang; Jianguo Lin; De Tan; Yanjuan Xu; Elizabeth M Brunt; Xiaofeng Fan; Adrian M Di Bisceglie
Journal:  Biochem Biophys Res Commun       Date:  2011-09-16       Impact factor: 3.575

Review 2.  Theoretical aspects of immunity.

Authors:  Michael W Deem; Pooya Hejazi
Journal:  Annu Rev Chem Biomol Eng       Date:  2010       Impact factor: 11.059

3.  HCV in liver transplantation.

Authors:  Giacomo Germani; Emmanuel Tsochatzis; Vasilios Papastergiou; Andrew K Burroughs
Journal:  Semin Immunopathol       Date:  2012-07-25       Impact factor: 9.623

Review 4.  NK cells, innate immunity and hepatitis C infection after liver transplantation.

Authors:  Anoma Nellore; Jay A Fishman
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

5.  Genetic diversity of hepatitis C virus predicts recurrent disease after liver transplantation.

Authors:  Hui Li; Daniel G Sullivan; Nathan Feuerborn; Susan McArdle; Kirubeal Bekele; Sampa Pal; Matthew Yeh; Robert L Carithers; James D Perkins; David R Gretch
Journal:  Virology       Date:  2010-04-18       Impact factor: 3.616

6.  Complexity and catalytic efficiency of hepatitis C virus (HCV) NS3 and NS4A protease quasispecies influence responsiveness to treatment with pegylated interferon plus ribavirin in HCV/HIV-coinfected patients.

Authors:  Ester Aparicio; Sandra Franco; Mariona Parera; Cristina Andrés; Cristina Tural; Bonaventura Clotet; Miguel Angel Martínez
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

7.  Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C.

Authors:  Hui Li; Brian J McMahon; Susan McArdle; Dana Bruden; Daniel G Sullivan; Dave Shelton; Heike Deubner; David R Gretch
Journal:  Virology       Date:  2008-03-17       Impact factor: 3.616

8.  Antiviral treatment for hepatitis C virus infection after liver transplantation.

Authors:  Yasuhiko Sugawara; Sumihito Tamura; Norihiro Kokudo
Journal:  Hepat Res Treat       Date:  2010-11-01

9.  Evidence for deleterious hepatitis C virus quasispecies mutation loads that differentiate the response patterns in IFN-based antiviral therapy.

Authors:  Yi Ren; Weihua Wang; Xiaoan Zhang; Yanjuan Xu; Adrian M Di Bisceglie; Xiaofeng Fan
Journal:  J Gen Virol       Date:  2015-11-18       Impact factor: 3.891

10.  Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization.

Authors:  Jason T Blackard; Gang Ma; Jeffrey A Welge; Christina M Martin; Kenneth E Sherman; Lynn E Taylor; Kenneth H Mayer; Denise J Jamieson
Journal:  J Med Virol       Date:  2012-02       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.